Emerging Question On OTC Switches: Too Many Choices For Consumers?
This article was originally published in The Pink Sheet Daily
Executive Summary
When considering potential Rx-to-OTC switches, FDA advisory committees likely will weigh whether consumers will have too many choices in OTC categories to make safe selections. As more drugs switch, industry should consider retiring outdated and obsolete drugs, says FDA official Sandra Kweder said.